Shire hit by a setback as Hunter syndrome drug fails late-stage study
Shire’s attempt to develop a new formulation of Elaprase that could be used to prevent cognitive decline in patients with rare cases of Hunter syndrome …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
